Leo Wealth’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.72M Buy
+60,136
New +$1.6M 0.36% 66
2026
Q1
$2.92M Sell
104,084
-31,777
-23% -$846K 0.21% 91
2025
Q4
$3.38M Buy
135,861
+27,559
+25% +$695K 0.25% 75
2025
Q3
$2.76M Sell
108,302
-21,721
-17% -$536K 0.36% 56
2025
Q2
$3.15M Buy
+130,023
New +$3.03M 0.25% 80
2025
Q1
– Sell
-35,767
Closed -$949K – 345
2024
Q4
$949K Buy
35,767
+11,722
+49% +$318K 0.09% 161
2024
Q3
$696K Sell
24,045
-5,658
-19% -$165K 0.06% 185
2024
Q2
$835K Sell
29,703
-17,477
-37% -$481K 0.09% 160
2024
Q1
$1.31M Sell
47,180
-28,482
-38% -$790K 0.13% 121
2023
Q4
$2.17M Buy
+75,662
New +$2.29M 0.23% 77

Other funds holding PFE

Leo Wealth's PFE Position: Q3 2026 in Review

Leo Wealth opened a new position in Pfizer (PFE) in Q3 2026: 60,136 shares worth $1.72M. The stake represents 0.36% of the portfolio and ranks #66 among its holdings. This is a return to the name: Leo Wealth previously reported a position in PFE as recently as Q1 2026.

Leo Wealth first reported a position in PFE in Q4 2023 and has held it in 10 quarters since. The position peaked at $3.38M in Q4 2025. 2,556 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Leo Wealth held 60,136 shares of Pfizer worth $1.72M as of Q3 2026.
  • Pfizer was a new Leo Wealth position in Q3 2026.
  • Pfizer made up 0.36% of Leo Wealth's portfolio in Q3 2026, its #66 holding.
  • Leo Wealth first reported a position in Pfizer in Q4 2023 and has held it in 10 quarters since.
  • Leo Wealth's Pfizer position peaked at $3.38M in Q4 2025.
  • 2,556 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Leo Wealth's 13F filing for Q3 2026, filed 26 Oct 2026.